Health

Companies engaged in biotechnology, pharmaceuticals, research services, home healthcare, hospital operations, long‑term care, and the manufacture and supply of medical equipment and supplies. The sector also includes pharmaceutical retailers and providers of health‑information services. UK‑listed companies in this sector include AstraZeneca plc, GlaxoSmithKline plc, Smith & Nephew plc, Hikma Pharmaceuticals plc, ConvaTec Group plc, Spire Healthcare plc and EMIS Group plc.

One Health Group's first trading update since its AIM listing reveals over 20% revenue growth, highlighting its strong market position and promising future in healthcare...
EDX Medical Group is set to revolutionise testicular cancer detection with a groundbreaking test boasting over 90% sensitivity...
As concerns over public health rise, understanding influenza's impact on healthcare evolves into a key opportunity for savvy investors in biotech and vaccine development...
Aptamer Group plc has released a new corporate presentation and investor factsheet, showcasing its strategic growth, operational progress, and financial performance in the life science industry...
One Health Group plc's trading update highlights impressive growth in NHS-funded procedures. Discover their revenue surge, new contracts, and plans for expansion...
Introducing the TC100 by EDX Medical: a revolutionary, non-invasive blood test transforming testicular cancer detection with AI precision and unmatched accuracy...
Navigating first-in-human trials requires precision. Learn how integrating real-world patient insights, like cannabis use, enhances drug development for schizophrenia...
DCC plc has agreed to sell its healthcare division to HealthCo Investment for £1.05 billion, streamlining operations and enhancing shareholder value...
The DESTINY-Breast09 Phase III trial of Enhertu marks a breakthrough for HER2-positive metastatic breast cancer, showcasing superior efficacy over traditional therapies...
HUTCHMED has successfully completed patient enrollment for a Phase II trial of savolitinib, targeting gastric cancer patients with MET amplification...
Discover One Health Group's innovative approach to back and spine care, blending advanced surgeries with non-invasive therapies for optimal patient outcomes...
GSK's Penmenvy vaccine is set to transform adolescent immunisation against meningococcal disease in the US, streamlining protection with fewer doses...
A groundbreaking blood test for testicular cancer, backed by actor Jack James Ryan, promises near-perfect accuracy and aims to transform early detection for men...
Discover how FluCamp pioneers clinical trials, bridging lab discoveries and revolutionary treatments, ensuring safety and efficacy in modern medicine...
Cizzle Biotechnology Holdings plc has launched a new corporate website, enhancing access to vital information about its early cancer tests and growth strategy...
Professor Sir Chris Evans, Founder and Chief Scientific Officer of EDX Medical, explains how this revolutionary blood test could reshape early diagnosis and monitoring..
Convatec Group Plc celebrates the CMS's postponement of LCDs for diabetic foot ulcers, ensuring continued access to their trusted InnovaMatrix® for Medicare patients...
Poolbeg Pharma is innovating in oncology with POLB 001, a promising p38 MAP kinase inhibitor targeting Cytokine Release Syndrome, a critical complication in cancer therapies...
One Health Group is set to transform orthopaedic care in the North of England with its first surgical hub, enhancing patient access to essential NHS services...
EDX Medical Group is set to launch TC100, a groundbreaking early detection test for testicular cancer in the UK, offering unparalleled accuracy for improved patient care...
Search

Funds

March 18, 2024

One Health Group's first trading update since its AIM listing reveals over 20% revenue growth, highlighting its strong market position and promising future in healthcare...
EDX Medical Group is set to revolutionise testicular cancer detection with a groundbreaking test boasting over 90% sensitivity...
As concerns over public health rise, understanding influenza's impact on healthcare evolves into a key opportunity for savvy investors in biotech and vaccine development...
Aptamer Group plc has released a new corporate presentation and investor factsheet, showcasing its strategic growth, operational progress, and financial performance in the life science industry...
One Health Group plc's trading update highlights impressive growth in NHS-funded procedures. Discover their revenue surge, new contracts, and plans for expansion...
Introducing the TC100 by EDX Medical: a revolutionary, non-invasive blood test transforming testicular cancer detection with AI precision and unmatched accuracy...
Navigating first-in-human trials requires precision. Learn how integrating real-world patient insights, like cannabis use, enhances drug development for schizophrenia...
DCC plc has agreed to sell its healthcare division to HealthCo Investment for £1.05 billion, streamlining operations and enhancing shareholder value...
The DESTINY-Breast09 Phase III trial of Enhertu marks a breakthrough for HER2-positive metastatic breast cancer, showcasing superior efficacy over traditional therapies...
HUTCHMED has successfully completed patient enrollment for a Phase II trial of savolitinib, targeting gastric cancer patients with MET amplification...
Discover One Health Group's innovative approach to back and spine care, blending advanced surgeries with non-invasive therapies for optimal patient outcomes...
GSK's Penmenvy vaccine is set to transform adolescent immunisation against meningococcal disease in the US, streamlining protection with fewer doses...
A groundbreaking blood test for testicular cancer, backed by actor Jack James Ryan, promises near-perfect accuracy and aims to transform early detection for men...
Discover how FluCamp pioneers clinical trials, bridging lab discoveries and revolutionary treatments, ensuring safety and efficacy in modern medicine...
Cizzle Biotechnology Holdings plc has launched a new corporate website, enhancing access to vital information about its early cancer tests and growth strategy...
Professor Sir Chris Evans, Founder and Chief Scientific Officer of EDX Medical, explains how this revolutionary blood test could reshape early diagnosis and monitoring..
Convatec Group Plc celebrates the CMS's postponement of LCDs for diabetic foot ulcers, ensuring continued access to their trusted InnovaMatrix® for Medicare patients...
Poolbeg Pharma is innovating in oncology with POLB 001, a promising p38 MAP kinase inhibitor targeting Cytokine Release Syndrome, a critical complication in cancer therapies...
One Health Group is set to transform orthopaedic care in the North of England with its first surgical hub, enhancing patient access to essential NHS services...
EDX Medical Group is set to launch TC100, a groundbreaking early detection test for testicular cancer in the UK, offering unparalleled accuracy for improved patient care...
Search

Funds

Health

FTSE 100

Funds